Eastman Chemical Company research snapshot
EMN AI stock analysis reads Eastman Chemical Company as a diversified specialty materials producer whose value rests on specialty polymers, films, additives, chemical intermediates, fibers, and circular-economy technology. At the August 3, 2026 data cutoff, EMN was quoted at $69.95 on July 31, 2026, with a verified market capitalization near $8.00 billion using 114.33 million shares. Eastman reported $2,513 million of second-quarter 2026 sales, up 10% year over year, $311 million of EBIT, $1.59 of diluted GAAP EPS, and $1.97 of adjusted EPS. First-half 2026 sales were $4,690 million, net earnings attributable to Eastman were $290 million, and adjusted EPS was $3.06. The company ended June 30, 2026 with $691 million of cash, $5,217 million of total borrowings, and $4,526 million of net debt. Management raised the earnings outlook trajectory, guided 2026 capital spending near $400 million, and expects operating cash flow to approach $900 million. The potential upside depends on continued specialty volume and price discipline, Chemical Intermediates spread strength, circular-platform scaling, and cost savings of $125 million to $150 million. The main risk is that the Middle East conflict, weak discretionary demand, raw-material costs, or debt service pressures returns in the second half. This page uses scenarios and explicit risk controls rather than a certain price prediction, and is for informational use only.
Current price
$69.95 July 31, 2026 market price
Market cap
$8.00 billion verified market capitalization
AI score
62 / 100
Rating
Specialty materials and chemicals platform showing a real earnings recovery in Q2 2026, while cycle exposure, debt, and Fibers weakness still limit certainty
Trend status
Mixed intermediate trend: price sits just below the 50-day moving average and just above the 200-day moving average, with RSI near 54
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Eastman sells specialty materials and chemical intermediates used in automotive, building, packaging, health, personal care, agriculture, energy, and filtration applications. Q2 2026 showed pricing power in specialties and strong spread expansion in Chemical Intermediates, but Fibers remains a drag and commodity-linked segments still shape consolidated results. | High |
| Moat | The moat comes from application know-how, vertical integration, global manufacturing scale, long customer relationships, brands such as Tritan, Saflex, LLumar, and Naia, plus a large patent and trademark portfolio. It is narrower in commodity intermediates, where advantage rises and falls with supply conditions. | Medium-high |
| Management | CEO Mark Costa has led Eastman since 2014 and emphasized portfolio management, specialty innovation, cost discipline, and circular projects. Management is executing $125 million to $150 million of net-of-inflation cost savings, keeping 2026 capex near $400 million, and noted the Kingsport methanolysis facility is ramping. The test is whether adjusted results convert into operating cash flow near $900 million while debt falls. | Medium-high |
| Financial trend | Second-quarter 2026 sales rose 10% to $2,513 million, EBIT rose to $311 million from $222 million, diluted EPS rose to $1.59 from $1.20, and adjusted EPS rose to $1.97 from $1.60. First-half operating cash flow was only $87 million due to receivables and inventories, so the second-half working capital release matters. | High |
| Valuation | At $69.95, tool math gives about 18.25x TTM EPS of $3.83, about 11.1x the consensus 2026 adjusted EPS near $6.31, 1.31x book value, 14.84x TTM free cash flow, and a 4.80% dividend yield. The multiple is reasonable if earnings and cash flow continue to recover, but it relies on spreads and volumes holding up. | Medium-high |
| Technical trend | StockAnalysis reported a 50-day moving average near $70.77, a 200-day average near $69.10, and RSI near 53.77. The July 31, 2026 quote sat just below the 50-day average and just above the 200-day average, which reads as mixed rather than clearly bearish. | Medium |
| Risk level | Risk is medium-high. Net debt was $4,526 million at June 30, 2026, Chemical Intermediates earnings depend partly on Middle East supply disruption, Fibers volumes are weak, raw-material and energy costs are volatile, and environmental and restructuring charges recur. Q2 2026 improved but did not remove these exposures. | High |
| AI confidence | Descriptive confidence is high for audited financial facts and Q2 2026 disclosures. Forecast confidence is medium because normalized earnings depend on the chemicals cycle, product mix, the Middle East conflict, project economics, and market valuation. | High data confidence |
| Investment certainty | Investment certainty is medium. The Q2 2026 earnings recovery and analyst consensus near an $80.87 target improve the setup, but weak price momentum above a 50-day average, Fibers weakness, and net debt keep certainty below a high conviction level. | Medium |
EMN AI stock forecast
The EMN AI stock forecast uses scenario math rather than a point prediction. The reference model starts with the consensus 2026 adjusted EPS estimate near $6.31, roughly 16% above 2025 adjusted EPS of $5.42, then applies three-year growth and terminal P/E assumptions. It produced about $120 in a bullish case, $88 in a base case, and $53 in a bearish case. These are valuation references, not promised prices, and they are sensitive to spreads, the Middle East conflict, Fibers demand, and the market multiple.
$110 to $130
More likely if specialty volumes and price discipline hold, Chemical Intermediates spreads stay strong, Fibers stabilizes, the circular platform scales with acceptable margins, cost savings land, and adjusted EPS grows about 8% annually while the market assigns a 16x multiple to 2028 earnings near $7.50.
$80 to $100
More likely if Eastman builds on the first-half recovery, 2026 adjusted EPS reaches the consensus range near $6.31, operating cash flow approaches $900 million, net debt declines, and investors assign about 13x to adjusted EPS near $6.80 in 2027.
$45 to $60
More likely if the Middle East conflict eases and Chemical Intermediates spreads compress, discretionary demand stays weak, Fibers keeps losing volume, raw-material or energy costs rise, circular-project returns disappoint, and adjusted EPS falls back toward $5.00 to $5.50 with a 9x to 10x multiple.
EMN AI technical analysis
EMN AI technical analysis is mixed at the August 3, 2026 data cutoff. StockAnalysis reported a $69.95 July 31, 2026 close, a 50-day moving average near $70.77, a 200-day moving average near $69.10, RSI near 53.77, and 20-day average volume of about 1.26 million shares. Price is just below the 50-day average and just above the 200-day average, so a sustained close above $70.77 would improve the intermediate trend, while a close below the 200-day average would keep the range repair unfinished.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $69.95 | StockAnalysis reported the July 31, 2026 market price used for this page. |
| Immediate support | $67.36 to $68 | The July 31, 2026 day range low was $67.36 in StockAnalysis data. A hold would keep the recent range intact, but it is not a confirmed reversal. |
| Major support | $56.11 | StockAnalysis reported the 52-week low near $56.11. A close below it would signal a materially weaker range. |
| First resistance | $70.77 to $72 | The 50-day moving-average area is the first trend-repair test, with round-number resistance near $72. |
| Major resistance | $75 to $83.47 | The upper range spans prior analyst target areas and the 52-week high of $83.47. A sustained close above $75 would improve the intermediate trend read. |
| Moving averages | 50-day near $70.77, 200-day near $69.10 | Price was slightly below the 50-day average and slightly above the 200-day average at the cutoff, which keeps the trend classification mixed. |
| Momentum | RSI near 53.77 | RSI is roughly neutral, leaving room in either direction. Momentum confirmation requires price and volume follow-through on a close above the 50-day average. |
| Volume | 20-day average near 1.26 million shares | A breakout above $70.77 or $72 should be checked against expanding volume. The static source does not establish a future volume signal. |
| Volatility | Beta 1.08; 52-week range $56.11 to $83.47 | StockAnalysis reported five-year beta of 1.08. Chemical-cycle earnings and event risk can still create moves larger than the beta suggests. |
| Invalidation | Close below $56.11 | A break below the 52-week low would invalidate the current range-recovery reference and require a fresh fundamental review. |
EMN AI trading strategy
The EMN AI trading strategy below is a rules-based research framework, not personal financial advice. It connects price action with segment margins, chemical spreads, raw-material costs, cash conversion, net debt, capital spending, recycling output, and dividend coverage.
Wait for EMN to reclaim and hold the $70.77 to $72.33 band while the next earnings commentary confirms stable specialty margins, sustained Chemical Intermediates spreads, and operating cash flow near the full-year expectation.
Treat a failed reclaim of the 50-day average or a close back below $67.36 as a loss of confirmation. Position size should reflect chemical-cycle and event risk tied to the Middle East conflict.
If EMN tests the mid-$60s without a new debt, dividend, or project problem, compare price with consensus adjusted EPS, free cash flow per share, book value, net debt, and the next earnings release before considering a rebound thesis.
Do not average down only because the dividend yield approaches 5%. Require evidence that operating cash flow can fund maintenance capital, the dividend, and debt obligations through a weak cycle.
Track Advanced Materials and AFP margins, Chemical Intermediates spreads, Fibers volumes, raw-material and energy costs, receivables, inventories, operating cash flow, capex near $400 million, net debt, recycling output, and cost savings of $125 million to $150 million.
Lower confidence if the Middle East conflict eases and spreads compress, cash conversion weakens, net debt rises, restructuring or environmental charges recur, or circular products lose their pricing and volume advantages.
Investment research summary
Customers pay Eastman for materials that improve safety, durability, appearance, filtration, packaging, comfort, and process performance. The best businesses inside the portfolio sell application-specific solutions, while chemical intermediates provide scale and integration but remain more cycle-sensitive, as the 2026 spread swing shows.
Eastman combines process chemistry, application development, manufacturing scale, customer qualification, vertical integration, brands, patents, and long relationships. The moat is stronger in specialty films, interlayers, copolyesters, additives, and fibers than in commodity intermediates.
The thesis fails if Middle East-driven supply disruptions ease and Chemical Intermediates spreads compress, weak discretionary demand keeps Fibers and specialty volumes soft, raw-material and energy costs rise faster than pricing, plant reliability suffers, or circular projects consume capital without sufficient customer adoption and margin.
Mark Costa has led Eastman since 2014 after strategy and business-development roles. The Q2 2026 result, cost-savings program, $400 million capex guidance, and methanolysis ramp show execution focus. The next test is whether adjusted earnings convert into operating cash flow near $900 million and a lower net debt balance.
Materials remain essential to transport, construction, health, packaging, and industrial production. Circularity and lower-carbon materials are long-term trends, but adoption depends on regulation, collection systems, feedstock economics, energy intensity, customer willingness to pay, and competing recycling technologies.
At $69.95, EMN trades near 18.25x TTM EPS, about 11.1x consensus 2026 adjusted EPS, and 1.31x book value with a 4.80% dividend yield. The margin of safety depends on whether normalized free cash flow can support the dividend, net debt of $4.53 billion, and the capital required for growth.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| EMN price | $69.95 on July 31, 2026 | StockAnalysis | August 3, 2026 |
| Market capitalization | $8.00 billion, verified as $69.95 x 114.33 million shares; tool deviation 0.03% | Financial rigor market-cap check and StockAnalysis | August 3, 2026 |
| Q2 2026 results | $2,513 million sales, $311 million EBIT, $1.59 diluted EPS, $1.97 adjusted EPS, $224 million operating cash flow | Eastman Q2 2026 earnings release (SEC Form 8-K Exhibit 99.01) | August 3, 2026 |
| First half 2026 results | $4,690 million sales, $290 million net earnings attributable to Eastman, $2.51 diluted EPS, $3.06 adjusted EPS | Eastman Q2 2026 earnings release tables filed with the SEC | August 3, 2026 |
| FY2025 revenue and earnings | $8,752 million revenue, $474 million net earnings attributable to Eastman, $4.10 diluted EPS | Eastman 2025 Form 10-K and StockAnalysis cross-check | August 3, 2026 |
| Cash, borrowings, and net debt | $691 million cash, $5,217 million total borrowings, and $4,526 million net debt at June 30, 2026 | Eastman Q2 2026 earnings release Table 6 | August 3, 2026 |
| Valuation snapshot | 18.25x TTM EPS, 10.37x forward earnings, 1.31x book, 14.84x TTM FCF, 4.80% annualized dividend yield | Financial rigor valuation check and StockAnalysis statistics | August 3, 2026 |
| Analyst consensus and forecast | Buy rating, average price target $80.87 (range $69 to $100) from 15 analysts; 2026 adjusted EPS estimate $6.31 | StockAnalysis forecast page | August 3, 2026 |
| Technical moving averages and momentum | 50-day MA $70.77, 200-day MA $69.10, RSI 53.77 | StockAnalysis statistics | August 3, 2026 |
| Price range and volume | 52-week range $56.11 to $83.47; 20-day average volume near 1.26 million shares; beta 1.08 | StockAnalysis statistics | August 3, 2026 |
This EMN AI stock analysis is an informational tool, not investment advice, a recommendation, or a promise of returns. Forecast ranges are scenario outputs based on available data and stated assumptions, and they can be wrong. Verify prices, filings, earnings, debt, taxes, dividends, and technical indicators independently before making any investment or trading decision.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
